Market
Primary reason cited for HHS extending COVID-19 vaccine liability protections by 2025?
2
Resolution / Starting Odds
Potential future pandemics • 25%
Vaccine manufacturer lobbying • 25%
Public health safety concerns • 25%
Other • 25%
Official statements or reports from HHS
Story
HHS Extends COVID-19 Vaccine Liability Protections Through 2029, Following 40 Years of Immunity Under NCVIA
Dec 10, 2024, 04:58 PM
The U.S. Department of Health and Human Services (HHS) has announced an extension of liability protections for manufacturers and administrators of COVID-19 vaccines until 2029. This decision aims to safeguard against potential health emergencies in the future. Since the enactment of the National Childhood Vaccine Injury Act in 1986, vaccine manufacturers have had immunity from lawsuits related to vaccine injuries. Most routine vaccines have enjoyed similar protections for nearly 40 years, while vaccines developed for emergencies have had protections for 20 years. The extension of these protections has been largely uncontroversial, according to experts.
View original story
Similar markets
Public Health Concerns • 25%
Legal Challenges • 25%
Political Pressure • 25%
No Amendment • 25%
Other reasons • 25%
Evolving pandemic conditions • 25%
Economic considerations • 25%
Political pressure • 25%
Other reasons • 25%
Perceived low risk of flu • 25%
Concerns about vaccine safety • 25%
Lack of access to vaccines • 25%
Decreased trust • 25%
Increased trust • 25%
Mixed responses • 25%
No significant change • 25%
Administrative changes • 25%
Industry pushback • 25%
Technical challenges • 25%
Other • 25%
Public health strategy shift • 25%
Other reasons • 25%
Economic impact concerns • 25%
Political ideology • 25%
United Kingdom • 25%
No International Challenge • 25%
European Union • 25%
Canada • 25%
National security concerns • 25%
No justification given • 25%
Mistake or oversight • 25%
Insufficient evidence • 25%
Security Threats • 25%
Technical Malfunctions • 25%
Other • 25%
Public Safety Concerns • 25%
No Challenge Filed • 25%
State Government • 25%
Non-profit Organization • 25%
Private Individual • 25%
Financial Concerns • 25%
Political Reasons • 25%
WHO Performance • 25%
Other • 25%